Literature DB >> 10851424

Rhenium-188--a generator-derived radioisotope for cancer therapy.

F F Knapp1.   

Abstract

Rhenium-188 (188Re) is an important therapeutic radioisotope which is obtained on demand as carrier-free sodium perrhenate by saline elution of the tungsten-188/rhenium-188 generator system. With a half-life of 16.9 hours and emission of a high energy beta particle (maximal energy of 2.12 MeV) and a gamma photon (155 keV, 15%) for imaging, 188Re can be provided at reasonable costs for routine preparation of radiopharmaceuticals for cancer treatment.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10851424     DOI： 10.1089/cbr.1998.13.337

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN： 1084-9785            Impact factor:   3.099


  15 in total

1.  188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.

Authors:  Amal A El-Mabhouh; John R Mercer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

Review 2.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

3.  Binding of ReO4(-) with an engineered MoO4(2-)-binding protein: towards a new approach in radiopharmaceutical applications.

Authors:  Baikuntha P Aryal; Pedro Brugarolas; Chuan He
Journal:  J Biol Inorg Chem       Date:  2011-08-23       Impact factor: 3.358

4.  May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate.

Authors:  Amir Sabet; Feras Khalaf; Soha Mahjoob; Abdullah Al-Zreiqat; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

5.  (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.

Authors:  Bieke Lambert; Klaus Bacher; Luc Defreyne; Hans Van Vlierberghe; Jae Min Jeong; Rong Fu Wang; Jan van Meerbeeck; Peter Smeets; Roberto Troisi; Hubert Thierens; Filip De Vos; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12-07       Impact factor: 9.236

6.  99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.

Authors:  Sandrine Ballot; Nicolas Noiret; François Hindré; Benoît Denizot; Etienne Garin; Holisoa Rajerison; Jean-Pierre Benoit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

7.  Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection.

Authors:  Ekaterina Dadachova; Antonio Nakouzi; Ruth A Bryan; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

8.  Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin.

Authors:  Ekaterina Dadachova; Joshua D Nosanchuk; Li Shi; Andrew D Schweitzer; Annie Frenkel; Jerome S Nosanchuk; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

Review 9.  Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Authors:  William T Phillips; Ande Bao; Andrew J Brenner; Beth A Goins
Journal:  Adv Drug Deliv Rev       Date:  2014-07-09       Impact factor: 15.470

10.  Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium.

Authors:  Kevin J H Allen; Rubin Jiao; Mackenzie E Malo; Ekaterina Dadachova
Journal:  Cancer Biother Radiopharm       Date:  2018-07-16       Impact factor: 3.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.